TauRx boost for Genting

Likely catalyst: People pass a Genting signage at a hotel in Singapore. The potential listing of Genting’s 20.7-owned TauRx on Nasdaq may provide a catalyst to Genting’s share price. – Reuters

Casino operator may gain from share in drug company

PETALING JAYA: The potential listing of Genting Bhd’s 20.7%-owned Alzheimer’s drugs company on Nasdaq could provide a catalyst to the share price of the Malaysian conglomerate.